Ligand validation:2JDM

MFU: methyl alpha-L-fucopyranoside

MFU is a Ligand Of Interest in 2JDM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2JDM_MFU_D_1117	85%	58%	0.088	0.953	0.81	0.82	1	-	0	0	100%	1
2JDM_MFU_C_1117	81%	48%	0.093	0.946	0.92	1.08	1	-	0	0	100%	1
2JDM_MFU_B_1117	81%	47%	0.108	0.96	1	1.03	1	2	0	0	100%	1
2JDU_MFU_D_1117	52%	41%	0.173	0.932	0.99	1.29	-	2	0	0	100%	1
2BOI_MFU_B_700	100%	70%	0.047	0.994	0.46	0.68	-	-	0	0	100%	1
4CSD_MFU_A_305	100%	55%	0.047	0.988	0.79	0.94	-	1	0	0	100%	1
7C39_MFU_B_402	99%	50%	0.05	0.985	1.34	0.63	2	-	0	0	100%	1
5MXC_MFU_A_403	98%	70%	0.061	0.986	0.6	0.56	-	-	0	0	100%	1
5A6X_MFU_A_201	96%	53%	0.066	0.974	0.53	1.27	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.